Pancreatic Cancer Research

ResearcherBiotheryx, Inc.Active in the last 2 years

Richard L. Klemke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8230-2915; OpenAlex author ID A5091345207; NIH RePORTER profile ID 1874802. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 4)
Trials
0
Grants
3
Labs led
1
Collaborators
14
Papers, trials and grants by year

2012: 1 paper · 2013: 1 grant · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper, 1 grant · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 grant · 2025: 2 papers

Papers 6

  1. A STAT3/integrin axis accelerates pancreatic cancer initiation and progression. Co-author DOI 10.1016/j.celrep.2025.116010↗
  2. The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.jbc.2025.110561↗
  3. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Last author DOI 10.1158/0008-5472.can-16-2594↗
  4. Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expressi… Last author DOI 10.1074/jbc.m115.687418↗
  5. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Last author DOI 10.1158/0008-5472.can-14-1031↗
  6. KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Last author DOI 10.1158/0008-5472.can-11-3552↗

Grants 3

  1. Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC R01CA182495↗
  2. Survival Mechanisms of Invasive Carcinoma Cells R01CA097022↗
  3. Pre-clinical development of a novel pancreatic cancer chemotherapeutic R43CA180398↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Carlotta Zampieri · 1 shared paper, 2025 · strength 0.30
  2. Steven L. Gonias · 1 shared paper, 2025 · strength 0.30
  3. David A Cheresh · 1 shared paper, 2025 · strength 0.20
  4. Alejandro D. Campos · 1 shared paper, 2025 · strength 0.20
  5. Valerie Marie Weaver · 1 shared paper, 2025 · strength 0.20
  6. Ken Fujimura · 3 shared papers, 2014–2017 · strength 0.16
  7. Ján Strnádel · 3 shared papers, 2014–2017 · strength 0.16
  8. Kyle W H Chan · 1 shared grant, 2013 · strength 0.15
  9. Michael Bouvet · 3 shared papers, 2012–2017 · strength 0.13
  10. Jonathan A. Kelber · 3 shared papers, 2012–2017 · strength 0.13
  11. Cristina Angela Metildi · 2 shared papers, 2012–2014 · strength 0.07
  12. Andrew M. Lowy · 2 shared papers, 2012–2014 · strength 0.07
  13. Kun‐Liang Guan · 1 shared paper, 2017 · strength 0.06
  14. Robert M. Hoffman · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.